Two Additional Appeals Rejected in Disease Team Round
The governing board of the California stem cell agency last night rejected appeals by two applicants -- OncoMed Pharmaceuticals of Redwood City and Albert Wong of Stanford -- in the $200 million disease team round.
Both petitions generated little discussion. You can find more on their petitions here and here.
The board also approved changes in its intelle…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.